Matthew William McCarthy (Matthew W McCarthy)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Cystic Fibrosis

Drug Administration

Top Venues

Clinical pharmacokinetics

Journal of clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew William McCarthy, Christopher John Lindsell, Radha Rajasingham, Thomas G Stewart, David R Boulware, Susanna Naggie
Progress toward realizing the promise of decentralized clinical trials. Journal of clinical and translational science 8 (1) (2024)
Matthew William McCarthy, Christopher John Lindsell, Radha Rajasingham, Thomas G Stewart, David R Boulware, Susanna Naggie
Progress toward realizing the promise of decentralized clinical trials. Journal of clinical and translational science 8 (1) (2024)
Matthew William McCarthy
Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections. Drugs in R&D 22 (2) (2022)
Matthew William McCarthy
Novel Strategies for the Treatment of COVID-19. Drugs in R&D 22 (4) (2022)
Matthew William McCarthy
Clinical Pharmacokinetics and Pharmacodynamics of Lefamulin. Clinical pharmacokinetics 60 (11) (2021)
Matthew William McCarthy
Pharmacokinetics and Pharmacodynamics of Ibrexafungerp. Drugs in R&D 22 (1) (2021)
Matthew William McCarthy
Clinical Pharmacokinetics and Pharmacodynamics of Imipenem-Cilastatin/Relebactam Combination Therapy. Clinical pharmacokinetics 59 (5) (2021)
Matthew William McCarthy
Clinical Pharmacokinetics and Pharmacodynamics of Eravacycline. Clinical pharmacokinetics 58 (9) (2020)